Can the response to a single dose of beclomethasone dipropionate predict the outcome of long-term treatment in childhood exercise-induced bronchoconstriction?
Asthma
exercise challenge test
exercise-induced bronchoconstriction
inhaled corticosteroids
pediatric
spirometry
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
09
05
2022
received:
02
02
2022
accepted:
13
05
2022
entrez:
27
6
2022
pubmed:
28
6
2022
medline:
29
6
2022
Statut:
ppublish
Résumé
Exercise-induced bronchoconstriction (EIB) is a frequent and highly specific symptom of childhood asthma. Inhaled corticosteroids (ICS) are the mainstay of controller therapy for EIB and asthma; however, a proportion of asthmatic children and adolescents is less responsive to ICS. We hypothesized that a single dose response to ICS could function as a predictor for individual long-term efficacy of ICS. To assess the predictive value of the bronchoprotective effect of a single-dose beclomethasone dipropionate (BDP) against EIB for the bronchoprotective effect of 4 weeks of treatment, using an exercise challenge test (ECT). Thirty-two steroid-naïve children and adolescents aged 6 to 18 years with EIB were included in this prospective cohort study. They performed an ECT at baseline, after a single-dose BDP (200µg) and after 4 weeks of BDP treatment (100 µg twice daily) to assess EIB severity. The response to a single-dose BDP on exercise-induced fall in FEV1 showed a significant correlation with the response on exercise-induced fall in FEV1 after 4 weeks of BDP treatment (r = .38, p = .004). A reduction in post-exercise fall in FEV1 of more than 8% after a single-dose BDP could predict BDP efficacy against EIB after 4 weeks of treatment with a positive predictive value of 100% (CI: 86.1-100%) and a negative predictive value of 29.4% (CI: 11.7%-53.7%). We found that the individual response to a single-dose BDP against EIB has a predictive value for the efficacy of long-term treatment with BDP. This could support clinicians in providing personalized management of EIB in childhood asthma.
Sections du résumé
BACKGROUND
Exercise-induced bronchoconstriction (EIB) is a frequent and highly specific symptom of childhood asthma. Inhaled corticosteroids (ICS) are the mainstay of controller therapy for EIB and asthma; however, a proportion of asthmatic children and adolescents is less responsive to ICS. We hypothesized that a single dose response to ICS could function as a predictor for individual long-term efficacy of ICS.
OBJECTIVE
To assess the predictive value of the bronchoprotective effect of a single-dose beclomethasone dipropionate (BDP) against EIB for the bronchoprotective effect of 4 weeks of treatment, using an exercise challenge test (ECT).
METHODS
Thirty-two steroid-naïve children and adolescents aged 6 to 18 years with EIB were included in this prospective cohort study. They performed an ECT at baseline, after a single-dose BDP (200µg) and after 4 weeks of BDP treatment (100 µg twice daily) to assess EIB severity.
RESULTS
The response to a single-dose BDP on exercise-induced fall in FEV1 showed a significant correlation with the response on exercise-induced fall in FEV1 after 4 weeks of BDP treatment (r = .38, p = .004). A reduction in post-exercise fall in FEV1 of more than 8% after a single-dose BDP could predict BDP efficacy against EIB after 4 weeks of treatment with a positive predictive value of 100% (CI: 86.1-100%) and a negative predictive value of 29.4% (CI: 11.7%-53.7%).
CONCLUSION
We found that the individual response to a single-dose BDP against EIB has a predictive value for the efficacy of long-term treatment with BDP. This could support clinicians in providing personalized management of EIB in childhood asthma.
Substances chimiques
Beclomethasone
KGZ1SLC28Z
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13808Informations de copyright
© 2022 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Références
Global initiative for Asthma. Global Strategy for Asthma Management and Prevention [Internet]. 2021. Available from: www.ginasthma.org
Hallstrand TS, Curtis JR, Aitken ML, Sullivan SD. Quality of life in adolescents with mild asthma. Pediatr Pulmonol. 2003;36(6):536-543.
Brasholt M, Baty F, Bisgaard H. Physical activity in young children is reduced with increasing bronchial responsiveness. J Allergy Clin Immunol. 2010;125(5):1007-1012.
Kojima N, Ohya Y, Futamura M, et al. Exercise-induced asthma is associated with impaired quality of life among children with asthma in Japan. Allergol Int. 2009;58(2):187-192.
Bossley CJ, Fleming L, Ullmann N, et al. Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach. Journal of Allergy and Clinical Immunology. 2016;138(2):413-420.e6.
Pruteanu AI, Chauhan BF, Zhang L, Prietsch SOM, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth. Cochrane Database Syst Rev. 2014(7):CD009878.
Zhang L, Lasmar LB, Castro-Rodriguez JA. The impact of asthma and its treatment on growth: an evidence-based review. J Pediatr (Rio J). 2019;95(Suppl 1):10-22.
Axelsson I, Naumburg E, Prietsch SO, Zhang L. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. Cochrane Database Syst Rev. 2019;2019(6):CD010126.
Petersen R, Agertoft L, Pedersen S. Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma. Eur Respir J. 2004;24(6):932-937.
Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987;79(4):653-659.
Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. Journal of Allergy and Clinical Immunology. 2005;115(2):233-242.
Zeiger R, Szefler S, Phillips B, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. Journal of Allergy and Clinical Immunology. 2006.
Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull. 2000;56(4):1054-1070.
Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J. 1998;12(5):1209-1218.
Stempel DA, Fuhlbrigge AL. Defining the responder in asthma therapy. J Allergy Clin Immunol. 2005;115(3):466-469.
Adcock IM, Ito K. Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol. 2004;4(3):257-262.
Adcock IM, Lane SJ. Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol. 2003;178(3):347-355.
Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol. 2000;106(6):1033-1042.
Duong-Thi-Ly H, Nguyen-Thi-Thu H, Nguyen-Hoang L, Nguyen-Thi-Bich H, Craig TJ, Duong-Quy S. Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review. J Int Med Res. 2017;45(6):1818-1830.
Adcock IM, Lane SJ. MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol. 2003;178(3):347-355.
Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109(3):410-418.
Licari A, Manti S, Castagnoli R, et al. Immunomodulation in pediatric asthma. Front Pediatr. 2019;7:289.
Manti S, Leonardi S, Parisi GF, et al. High mobility group box 1: biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma. Allergy Asthma Proc. 2017;38(3):197-203.
Sonntag HJ, Filippi S, Pipis S, Custovic A. Blood biomarkers of sensitization and asthma. Front Pediatrics. 2019;7:251.
Fitzpatrick AM, Jackson DJ, Mauger DT, et al. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016;138(6):1608-1618.
Thio BJ, Slingerland GLM, Nagelkerke AF, Roord JJ, Mulder PGH, Dankert-Roelse JE. Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study. Pediatr Pulmonol. 2001;32(2):115-121.
Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JWJ. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction. Eur Respir J. 2004;23(4):559-564.
Kippelen P, Larsson J, Anderson SD, et al. Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction. Med Sci Sports Exerc. 2010;42(2):273-280.
Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O’Connor BJ. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J Allergy Clin Immunol. 2002;110(4):603-606.
Visser R, Wind M, de Graaf B, de Jongh FHC, van der Palen J, Thio BJ. Protective effect of a low single dose inhaled steroid against exercise induced bronchoconstriction. Pediatr Pulmonol. 2015;50(12):1178-1183.
Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65.
Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119(4):817-825.
Loeb JS, Blower WC, Feldstein JF, Koch BA, Munlin AL, Hardie WD. Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria. Pediatr Pulmonol. 2008;43(10):1020-1024.
van Leeuwen JC, Driessen JMM, de Jongh FHC, Anderson SD, Thio BJ. Measuring breakthrough exercise-induced bronchoconstriction in young asthmatic children using a jumping castle. J Allergy Clin Immunol. 2013;131(5):1427-1429.e5.
Hallstrand TS, Leuppi JD, Joos G, et al. ERS technical standard on bronchial challenge testing: Pathophysiology and methodology of indirect airway challenge testing. Eur Respir J. 2018;52(5):1801033.
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
Anderson SD, Kippelen P. Assessment of EIB: What you need to know to optimize test results. Immunol Allergy Clin North Am. 2013;33(3):pp. 363-80, viii.
Kersten ETG, Akkerman-Nijland AM, Driessen JMM, Diamant Z, Thio BJ. Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction? Pediatr Pulmonol. 2016;51(5):470-477.
Visser R, Driessen J, Akkerman AM, van der Palen BJT. Predicting the effect of long term treatment with BDP by a single dose effect: a pilot study. Unpublished manuscript. 2012.
Anderson SD. ‘Indirect’ challenges from science to clinical practice. Eur Clin Respirat J. 2016;3(1):31096
Anderson SD, du Toit JI, Rodwell LT, Jenkins CR. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol: Outcome before and during treatment with aerosol corticosteroids in patients with asthma. Chest. 1994;105(3):673-680.
Ramadan AA, Gaffin JM, Israel E, Phipatanakul W. Asthma and corticosteroid responses in childhood and adult asthma. Clin Chest Med. 2019;40(1):163-177.
Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J. 2006;27(1):172-187.
Verrière VA, Hynes D, Faherty S, et al. Rapid effects of dexamethasone on intracellular pH and Na+/H+ exchanger activity in human bronchial epithelial cells. J Biol Chem. 2005;280(43):35807-35814.
Zhou J, Liu D-F, Liu C, et al. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism. Allergy. 2008;63(9):1177-1185.
Perretti M, Ahluwalia A. The microcirculation and inflammation: site of action for glucocorticoids. Microcirculation. 2000;7(3):147-161.
Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005;115(2):233-242.
Zeiger R, Szefler S, Phillips B, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. Journal of Allergy and Clinical Immunology. 2006;117(1):45-52.
Godfrey S, Springer C, Noviski N, Maayan C, Avital A. Exercise but not methacholine differentiates asthma from chronic lung disease in children. Thorax. 1991;46(7):488-492.
Godfrey S, Springer C, Bar-Yishay E, Avital A. Cut-off points defining normal and asthmatic bronchial reactivity to exercise and inhalation challenges in children and young adults. Eur Respir J. 1999;14(3):659-668.
Godfrey S. What is asthma? Arch Dis Child. 1985;60(11):997-1000.
Balfour-Lynn L, Tooley M, Godfrey S. Relationship of exercise-induced asthma to clinical asthma in childhood. Arch Dis Child. 1981;56(6):450-454.
Weiler JM, Brannan JD, Randolph CC, et al. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol. 2016;138(5):1292-1295.e36.
Jónasson G, Carlsen KH, Hultquist C. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatric Allergy Immunol. 2000;11(2):120-125.
Madhuban AA, Driessen JM, Brusse-Keizer MG, van Aalderen WM, de Jongh FH, Thio BJ. Association of the asthma control questionnaire with exercise-induced bronchoconstriction. J Asthma. 2011;48(3):275-278.
Rapino D, PietroConsilvio N, Scaparrotta A, et al. Relationship between exercise-induced bronchospasm (EIB) and asthma control test (ACT) in asthmatic children. J Asthma. 2011;48(10):1081-1084.
Rapino D, Attanasi M, Consilvio NP, et al. Evaluation of association between airway hyperresponsiveness, asthma control test, and asthma therapy assessment questionnaire in asthmatic children. Multidiscip Respir Med. 2013;8(1):48.
Chinellato I, Piazza M, Sandri M, et al. Evaluation of association between exercise-induced bronchoconstriction and childhood asthma control test questionnaire scores in children. Pediatr Pulmonol. 2012;47(3):226-232.
Haby MM, Peat JK, Mellis CM, Anderson SD, Woolcock AJ. An exercise challenge for epidemiological studies of childhood asthma: Validity and repeatability. Eur Respir J. 1995;8(5):729-736.